84 results match your criteria: "Cardiology and Aortic Centre[Affiliation]"
J Card Surg
May 2022
Department of Vascular Surgery, University Hospital of Wales, Cardiff, Wales, UK.
Background: Uncomplicated type B aortic dissection (un-TBAD) has been managed conservatively with medical therapy to control the heart rate and blood pressure to limit disease progression, in addition to radiological follow-up. However, several trials and observational studies have investigated the use of thoracic endovascular aortic repair (TEVAR) in un-TBAD and suggested that TEVAR provides a survival benefit over medical therapy. Outcomes of TEVAR have also been linked with the timing of intervention.
View Article and Find Full Text PDFLancet Reg Health Eur
March 2022
Cardiology and Aortic Centre, Royal Brompton Hospital and Harefield Trust, Sydney Street, London SW3 6NP, UK.
J Card Surg
April 2022
Department of Vascular and Endovascular Surgery, Velindre University NHS Trust, Health Education and Improvement Wales, Wales, UK.
Background: The use of thoracic endovascular aortic repair (TEVAR) for the management of uncomplicated type B aortic dissection (un-TBAD) remains controversial. There is a lack of consensus over whether pre-emptive TEVAR should be carried out in patients with un-TBAD at risk of progression to complicated TBAD. We present a review of current evidence and seek to suggest criteria where endovascular intervention in un-TBAD may prove beneficial relative to pharmacotherapy alone.
View Article and Find Full Text PDFJ Card Surg
April 2022
Department of Vascular Surgery, University Hospital of Wales, Heath Park, Cardiff, Wales, UK.
Background: Uncomplicated Stanford Type B aortic dissection (un-TBAD) is characterized by a tear in the aorta distal to the left subclavian artery without ascending aorta and arch involvement. Optimized cardiovascular control (blood pressure and heart rate) is the current gold standard treatment according to current international guidelines. However, emerging evidence indicates that thoracic endovascular aortic repair (TEVAR) is both safe and effective in the treatment of un-TBAD with improved long-term survival outcomes in combination with optimal medical therapy (OMT) relative to OMT alone.
View Article and Find Full Text PDFEur J Cardiothorac Surg
March 2022
Department for Vascular and Endovascular Surgery, Munich Aortic Center (MAC), Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
Objectives: Pleural effusions (PEffs) are known to occur in type B acute aortic dissection (TBAAD). We investigated the relationship between pleural effusion and the development of early or late complications following TBAAD.
Methods: The incidence of PEff (defined as at least an obliteration of the costophrenic angle in a frontal projection) diagnosed on their initial chest X-ray in patients with TBAAD enrolled in the International Registry of Acute Aortic Dissection was examined.
J Am Coll Cardiol
November 2021
Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain.
The purpose of this paper is to describe all available evidence on the distinctive features of a group of 4 life-threatening acute aortic pathologies gathered under the name of acute aortic syndrome (AAS). The epidemiology, diagnostic strategy, and management of these patients has been updated. The authors propose a new and simple diagnostic algorithm to support clinical decision making in cases of suspected AAS, thereby minimizing diagnostic delays, misdiagnoses, and unnecessary advanced imaging.
View Article and Find Full Text PDFJ Thorac Cardiovasc Surg
August 2023
Cardiology and Aortic Centre, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Department of Cardiology, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom.
Although Thoracic Endovascular Aortic Repair is usually applied to patients without connective tissue disorders, our case shows its potential for complicated type B aortic dissection in a Marfan patient as a feasible alternative to open redo surgery with good short-term outcomes.
View Article and Find Full Text PDFEur J Cardiothorac Surg
September 2021
Department of Vascular and Endovascular Surgery, Hubertus Hospital Berlin, Berlin, Germany.
JTCVS Tech
December 2020
Cardiology and Aortic Centre, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom.
Objective: Thoracic endovascular aortic repair (TEVAR) is recommended for type B aortic dissection and recently has even been used in selected cases of proximal (Stanford type A) aortic dissections in scenarios of prohibitive surgical risk. However, mechanical interactions between the native aorta and stent-graft are poorly understood, as some cases ended in failure. The aim of this study is to explore and better understand biomechanical changes after TEVAR and predict the result via virtual stenting.
View Article and Find Full Text PDFEndografting for atretic coarctation is technically feasible to avoid the risks of open surgery. It requires a strategic and structured endovascular approach such as the "Railway" technique for safe and successful restructuring of complete aortic atresia and avoiding rupture or bleeding.
View Article and Find Full Text PDFJ Thorac Cardiovasc Surg
July 2022
Department of Cardiac Surgery, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom.
Eur Heart J Case Rep
January 2021
Department of Cardiology and Aortic Centre, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London SW36NP, UK.
Background: Aortic complications can happen during left ventricular assist devices (LVADs) insertion and its treatment remains challenging. Percutaneous aortic interventions can be an alternative to surgery in such high-risk cases.
Case Summary: We present a patient with idiopatic dilated cardiomyopathy and advanced heart failure requiring LVAD insertion as a bridge to transplant, who developed an aortic pseudoaneurysm below the anastomosis of the LVAD tube.
Eur J Cardiothorac Surg
May 2021
Department of Vascular and Endovascular Surgery, Hubertus Hospital Berlin, Berlin, Germany.
J Thorac Cardiovasc Surg
July 2022
Cardiology and Aortic Centre, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom; National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom.
Eur Heart J
November 2020
Cardiology and Aortic Centre, Royal Brompton & Harefield Hospital NHS Foundation Trust, London SW3 6NP, UK, Department of Cardiology, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, UK.
J Endovasc Ther
February 2021
State Key Laboratory of Cardiovascular Disease, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Xicheng District, Beijing, China.
Purpose: To evaluate the safety and feasibility of the in situ needle fenestration (ISNF) technique for reconstruction of the left subclavian artery (LSA) during thoracic endovascular aortic repair (TEVAR) of complicated aortic arch pathologies.
Materials And Methods: A retrospective review was conducted from January 2014 to December 2019 of 50 patients (mean age 60.2±11.
Curr Probl Cardiol
March 2021
Cardiology Department, Nicosia General Hospital, Nicosia, Cyprus; Cardiology and Aortic Centre, Royal Brompton & Harefield NHS Foundation Trust, London.
The prevalence of heart failure has an increasing tendency in the last years. Either heart failure with reduced ejection fraction (HFrEF) or with preserved ejection fraction, the treatment depends on the severity, cause, and symptoms. In case of HFrEF, careful evaluation of patient is essential for proper diagnosis, risk stratification and treatment, which should always be individualistic.
View Article and Find Full Text PDFJ Thorac Dis
June 2020
Cardiology and Aortic Centre, Royal Brompton and Harefield Hospital NHS Foundation Trust, London, UK.
Cardiol Res
August 2020
Cardiology Department, Nicosia General Hospital, 2029, Nicosia, Cyprus.
The most common congenital heart disease is the bicuspid aortic valve. Understanding the pathophysiology and the altered hemodynamics is a key component for the diagnosis, risk stratification and treatment. Among others, aortic valve stenosis is the most common complication.
View Article and Find Full Text PDFJ Thorac Cardiovasc Surg
January 2022
School of Biomedical Engineering and Imaging Science, King's College London, St Thomas' Hospital, London, United Kingdom; Department of Vascular Surgery, St George's Hospital, London, United Kingdom.
Eur Heart J
October 2020
Department of Cardiology, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK.
J Thorac Cardiovasc Surg
October 2021
Cardiology and Aortic Centre, Royal Brompton and Harefield Hospital NHS Foundation Trust, London, United Kingdom; Department of Cardiology, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom.
J Thorac Cardiovasc Surg
August 2021
Cardiology and Aortic Centre, Royal Brompton and Harefield Hospital NHS Foundation Trust, London, United Kingdom; Faculty of Medicine, Department of Cardiology, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Ann Thorac Surg
November 2020
Service of Interventional Radiology, Ospedale Regionale di Lugano, Lugano, Switzerland.
Background: The ASSIST (A multicentre Study in Survivors of type B aortic dissection undergoing Stenting) study compared both 1-year outcomes and evolution of true and false lumen (eg, remodeling) in patients with complicated type B aortic dissection subjected to thoracic endovascular aortic repair (TEVAR) with distal true lumen scaffolding by self-expanding nitinol open stent in comparison with TEVAR alone.
Methods: The ASSIST study was a multicenter prospective single-arm study comparing clinical and imaging data from 39 consecutive patients (59.4 ± 13 years of age) who received TEVAR and the JOTEC E-XL open stent with data from matched control subjects treated with TEVAR alone based on 1:1 propensity score matching.